Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. HTZ
6. MRK
7. TTWO
8. USO
9. QCOM
10. INFY

Go back to Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance

Integra LifeSciences (IART) Tops Q4 EPS by 4c; Offers FY23 Guidance

February 22, 2023 6:03 AM EST

Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.94, $0.04 better than the analyst estimate of $0.90. Revenue for the quarter came in at $398 million versus the consensus estimate of $397.52 million.

GUIDANCE:

Integra LifeSciences sees FY2023 EPS of $3.43-$3.51, versus the consensus of $3.52.... More